Quent Capital’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.58K Sell
15
-5
-25% -$2.58K ﹤0.01% 1324
2026
Q2
$9.32K Buy
20
+3
+18% +$1.26K ﹤0.01% 1264
2026
Q1
$6.43K Buy
17
+5
+42% +$2.14K ﹤0.01% 1236
2025
Q4
$5.14K Sell
12
-18
-60% -$7.84K ﹤0.01% 1268
2025
Q3
$13.4K Buy
+30
New +$13.6K ﹤0.01% 959
2025
Q2
– Sell
-21
Closed -$12.9K – 449
2025
Q1
$12.9K Sell
21
-1
-5% -$568 ﹤0.01% 860
2024
Q4
$11.7K Buy
22
+1
+5% +$564 ﹤0.01% 905
2024
Q3
$12.6K Sell
21
-3
-13% -$1.7K ﹤0.01% 972
2024
Q2
$13K Hold
24
– – ﹤0.01% 950
2024
Q1
$15.4K Sell
24
-1
-4% -$608 ﹤0.01% 940
2023
Q4
$14.6K Buy
25
+2
+9% +$1.12K ﹤0.01% 904
2023
Q3
$12K Hold
23
– – ﹤0.01% 897
2023
Q2
$12.5K Buy
23
+4
+21% +$2.19K ﹤0.01% 892
2023
Q1
$10.2K Hold
19
– – ﹤0.01% 917
2022
Q4
$9.7K Buy
19
+13
+217% +$6.33K ﹤0.01% 901
2022
Q3
$3K Hold
6
– – ﹤0.01% 1033
2022
Q2
$3K Buy
6
+3
+100% +$1.46K ﹤0.01% 1006
2022
Q1
$2K Sell
3
-4
-57% -$1.92K ﹤0.01% 1136
2021
Q4
$4K Buy
+7
New +$3.36K ﹤0.01% 937

Other funds holding CHE

Quent Capital's CHE Position: Q3 2026 in Review

Quent Capital reduced its Chemed (CHE) stake by 25% in Q3 2026, selling an estimated $2.58K and leaving 15 shares worth $7.58K. The position accounts for ﹤0.01% of the portfolio, ranked #1324.

Quent Capital first reported a position in CHE in Q4 2021 and has held it in 19 quarters since. The position peaked at $15.4K in Q1 2024. 544 funds tracked by Wall St. Rank hold CHE as of Q3 2026.

  • Quent Capital held 15 shares of Chemed worth $7.58K as of Q3 2026.
  • Quent Capital sold 5 Chemed shares in Q3 2026, an estimated $2.58K.
  • Chemed made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #1324 holding.
  • Quent Capital first reported a position in Chemed in Q4 2021 and has held it in 19 quarters since.
  • Quent Capital's Chemed position peaked at $15.4K in Q1 2024.
  • 544 funds tracked by Wall St. Rank held Chemed as of Q3 2026.

Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.